Tag - Myomo

Myomo to Present at The MicroCap Conference

Ziad2022-11-25T14:04:54-05:00Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will be presenting at The MicroCap Conference on Monday, October 1st at 11:00 AM EDT, Track 1, Essex House in New York City. Read more >>

High-tech brace allows Mechanicsburg teen use left arm again

Ziad2022-11-25T14:04:54-05:00Dees is the first adolescent worldwide to use the MyoPro 2 — a powered arm brace designed to restore movement to paralyzed or weakened arms — out of trials, according to Jonathan Naft, vice president of Myomo, a medical robotics company based in Cambridge, Massachusetts, that takes it names from “my own motion.” Read more >>

Myomo Appoints Micah Mitchell as Chief Commercial Officer

Ziad2022-11-25T14:04:54-05:00Myomo, Inc., a wearable medical robotics company, announced today that Micah Mitchell is joining the company as chief commercial officer (CCO), a newly created executive role. The addition of a CCO reflects Myomo’s transition from a controlled introduction of its proprietary MyoPro product line to expansion of its sales, marketing, and distribution activities to address the large unmet need of expanded mobility for individuals with arm and hand paralysis. Read more >>

TBI Study Using the Myomo MyoPro Suggests Promising Results

Ziad2022-11-25T14:04:54-05:00Promising preliminary case results from a clinical trial evaluating the effects of the MyoPro myoelectric arm orthosis (powered brace) from Myomo on traumatic brain injury (TBI) patients at the Cleveland VA Medical Center were presented recently at the American Academy of Orthotists and Prosthetists Annual Scientific Meeting. Read more >>

MyoPro Powered Arm Brace Now Available for Teens with MS or Injuries, Myomo Announces

Ziad2022-11-25T14:05:04-05:00Myomo, a wearable medical robotics company, announced that MyoPro — its myoelectric orthosis or powered brace — is now available for use by teenagers with paralyzed or weakened arms due to injuries or neurological disorders such as multiple sclerosis (MS). Read more >>

Myomo® Application for Medicare Codes Receives Favorable Preliminary Decision

Ziad2022-11-25T14:05:05-05:00Myomo, Inc., a wearable medical robotics company, announces that the Centers for Medicare & Medicaid Services ("CMS") has published a favorable preliminary decision regarding the Company’s application for Healthcare Common Procedure Coding System (HCPCS) “L” codes. Myomo had filed its application in December 2017 to have CMS establish two new Level II HCPCS codes to describe “microprocessor-controlled, custom fabricated upper extremity braces. Read more >>

Meet Paul Gudonis, CEO of Myomo

Ziad2022-11-25T14:05:05-05:00Myomo is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Read more >>

Myomo Welcomes 13 New Center of Excellence Locations

Ziad2022-11-25T14:05:15-05:00Myomo, Inc., a commercial stage medical robotics company, today announced the addition of three new orthotics and prosthetics (O&P) practices and 13 new locations to its MyoPro Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered orthoses. The addition of the practices brings the total number of CoE locations across the United States to 46. Read more >>

Myomo Announces Participation at Upcoming Investor and Partnering Conferences

Ziad2022-11-25T14:05:15-05:00Myomo, Inc., a commercial stage medical robotics company, today announced that Chairman and Chief Executive Officer Paul R. Gudonis will be participating at two upcoming investor, partnering and collaboration conferences. Read more >>

Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center

Ziad2022-11-25T14:05:16-05:00Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences Center (MLSC) today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011. Myomo completed repayment of the loan, which totaled $1,350,618 with interest, on December 13, 2017. Myomo Chairman and CEO Paul R. Gudonis presented a ceremonial check to Travis McCready, President and CEO of MLSC, during a ceremony at Myomo’s headquarters in the Cambridge...